Specifically, studies have shown that the use of epidrugs, such as DNMT inhibitors or LSD1 inhibitors, can induce TE expression, resulting in activation of an immune response, and that the combination of these epi-drugs with immunotherapy results in increased death of cancer cell [23,24]. The gene discussed is KDM1A; the disease is cancer.